GST NEWS
Pharma stockists see fall in business transactions post-GST: survey
Pharma stockists see fall in business transactions post-GST: survey
Sep 13, 2017

With retailers staying cautious in building up inventories of drugs, chemists and stockists of pharmaceutical products reported a fall in transactions after the goods and services tax (GST) took effect on 1 July, according to a pan-India survey conducted by global healthcare information provider QuintilesIMS.

For this survey, QuintilesIMS interviewed 350 stockists and 149 chemists to study the impact of GST on the pharma supply chain. 90% of the stockists said their sales to chemists had declined post-GST.

Of the total, 34% stockists said the fall in sales was up to 10%, while 9% stockists said the decline was over 40%.

In transition to GST, retailers were trying to clear their stocks, which is why stockists saw an impact on their business. Overall inventory building at stockist as well as the retail level remained subdued, Prem Sethi, director, new offerings development and product management at QuintilesIMS, said.

According to the market research unit of the All India Organisation of Chemists and Druggists (AIOCD), distributors or stockists were holding 28 days of inventories as of 7 August, which is higher than 17 days as of June-end but still lower than average inventory of 40 days at the end of May.

Ahead of the debut of GST on 1 July, medicine distributors had reduced stocks to avoid potential losses. Under GST, most medicines are taxed at 12%, while life-saving drugs, including insulin, are taxed at 5%.

On the pre-GST stock, distributors can avail of 100% credit on Cenvat (central value added tax) if they possess a central excise invoice issued by the manufacturer, importer, super-stockist or carrying and forwarding (C&F) agent. In case they do not have an excise invoice, then credit can be availed of only on 40% of the central GST, which could lead to losses.

The de-stocking in the trade channel ahead of GST impacted India business growth of most pharmaceutical companies in the quarter ended June.

The Indian pharmaceutical market contracted 2.4% on year to Rs9,280 crore in July due to operational issues faced by the industry for GST implementation, as per data from the market research unit of AIOCD. The market showed modest improvement in August, registering on-year growth of 2.4% to Rs10,317 crore.

According to QuintilesIMS survey, stockists and chemists believe teething troubles on GST implementation will end in one to three months. Already 97% of stockists and 61% of chemists have upgraded their software in accordance with GST policy and the remaining are likely to do so in up to three months.

On the whole GST is expected to bring in operational efficiency in the supply chain as inter-state transactions will become tax-neutral and companies may no longer need state-wise carrying and forwarding agents but stockists and chemists have not seen such efficiencies playing out so far, as per the survey.

Source :  Livemint

Top Stories
Government extends deadline for filing of GSTR 1 for July to October 10
The government on Saturday said it is extending the deadline to file GSTR 1 for July to October 10. ...
Sep 9, 2017
600 Views
Government extends deadline to file GST TRAN 1 till October 31
After a lot of confusion, the Government has clarified and extended the filing of GST TRAN 1 to Octo...
Sep 22, 2017
134 Views
GST Council to meet on October 6, may dole out sops to exporters
The 22nd meeting of the GST Council, chaired by Union Finance Minister Arun Jaitley, will be held on...
Sep 19, 2017
50 Views
Only Rs 12,000-cr credit claims valid
The government on Friday said only Rs 12,000 crore of the Rs 65,000 crore of input tax credit claime...
Sep 23, 2017
248 Views
India's first post-GST budget process to begin next week: Here's why Budget 2018 matters a lot to Modi govt
Work on India's first post-GST Union Budget 2018-19 will start next week with the finance ministry i...
Sep 10, 2017
694 Views
Articles on GST